TransMedics Group Inc vs Verisign, Inc. — how do they compare? TransMedics Group Inc trades at $74.3 (market cap $2.54B), while Verisign, Inc. trades at $277.5 (market cap $25.26B). The key difference: Verisign, Inc. is far larger — about 9.9× TransMedics Group Inc's market cap, and Verisign, Inc. pays a 1.17% dividend while TransMedics Group Inc pays none. Which is the better fit depends on your goals.
| TMDX | VRSN | |
|---|---|---|
Market Cap | $2.54B | $25.26B |
Sector | Technology | Technology |
52-Week High | $150.42 | $310.00 |
52-Week Low | $61.99 | $211.49 |
Enterprise Value | $2.94B | $26.50B |
Dividend Yield | — | 1.17% |
Trailing returns across standard periods
Latest headlines on both assets
TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →Verisign is the sole authorized registry for several generic top-level domains, including the widely utilized .com and .net top-level domains. The company operates critical Internet infrastructure to support the domain name system, including operating two of the world's 13 root servers that are used to route Internet traffic. In 2018, the firm sold off its Security Services business, signalling a renewed focus on the core registry business.
Read more on VRSN →